Blog
RSS FeedPosted by Michael Wonder on 03 Apr 2023
Nucala (mepolizumab) is now listed on the PBS for Australians with chronic rhinosinusitis with nasal polyps
3 April 2023 - Nucala is the first biologic treatment to be PBS-subsidised for the treatment of severe chronic rhinosinusitis with ...
Posted by Michael Wonder on 01 Apr 2023
Schedule of Pharmaceutical Benefits - 1 April 2023
1 April 2023 - The April 2023 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 30 Mar 2023
Expanded access to subsidised oral antiviral Paxlovid and other COVID-19 supports
30 March 2023 - From 1 April, more than 160,000 people aged 60 to 69 will have access to the ...
Posted by Michael Wonder on 29 Mar 2023
Agenda for the July 2023 PBAC meeting
29 March 2023 - The agenda for the July 2023 PBAC meeting is now available. ...
Posted by Michael Wonder on 22 Mar 2023
HTA reform gets underway – terms of reference released today
22 March 2023 - Medicines Australia acknowledges the Health Technology Assessment Review Terms of Reference – released today – and ...
Posted by Michael Wonder on 22 Mar 2023
Terms of reference for the Health Technology Assessment Policy and Methods Review
22 March 2023 - The terms of reference for the Health Technology Assessment Policy and Methods Review is now available. ...
Posted by Michael Wonder on 19 Mar 2023
Public Summary Documents (first time decisions not to recommend and deferrals) - November 2022 PBAC meeting
17 March 2023 - The Public Summary Documents (first time decisions not to recommend and deferrals) from the November 2022 PBAC ...
Posted by Michael Wonder on 17 Mar 2023
Government maintains access to fast acting insulin
17 March 2023 - The Albanese Government has secured access to Fiasp and Fiasp FlexTouch on the PBS for Australians ...
Posted by Michael Wonder on 14 Mar 2023
CEO’s appointment to HTA Review Reference Committee
15 March 2023 - CEO of Medicines Australia, Elizabeth de Somer, has been appointed as the medicines industry representative on ...
Posted by Michael Wonder on 09 Mar 2023
AMA urges immediate action to save patients on PBS medicines
9 March 2023 - The AMA has urged all members of the Federal Parliament to support the AMA’s campaign to bring ...
Posted by Michael Wonder on 07 Mar 2023
DoH makes further tweaks to the agenda for this week's PBAC meeting
7 March 2023 - We are now at version 4 with four revisions. ...
Posted by Michael Wonder on 05 Mar 2023
Catherine has stage four breast cancer, but she can't access a new treatment in Australia
3 March 2023 - In 2015, twelve weeks after the birth of her second daughter, Catherine King was diagnosed with late-stage ...
Posted by Michael Wonder on 05 Mar 2023
3.2 million cheaper medicine in 2023
5 March 2023 - Australians are being encouraged to fill their prescriptions for medicines, especially as the maximum out of pocket ...
Posted by Michael Wonder on 03 Mar 2023
Public Summary Documents – November 2022 PBAC meeting (round 1)
3 March 2023 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the November 2022 PBAC ...
Posted by Michael Wonder on 03 Mar 2023
DoH tweaks the agenda for next week's PBAC meeting (2023/1)
3 March 2023 - We are now up to version 3; six revisions including two withdrawn submissions. ...